Bellerophon Therapeutics Stock Price

-0.29 (-6.52%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Bellerophon Therapeutics Inc BLPH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.29 -6.52% 4.16 00:00:09
Open Price Low Price High Price Close Price Prev Close
4.40 4.12 4.40 4.16 4.45
Bid Price Ask Price Spread News
4.06 4.90 0.84 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
332 67,807 $ 4.25 $ 287,939 - 3.79 - 13.22
Last Trade Time Type Quantity Stock Price Currency
18:59:29 6 $ 4.38 USD


Draw Mode:

Bellerophon Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 39.55M 9.51M 7.89M $ - $ - -3.29 -1.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.32M 39.00%

more financials information »

Bellerophon Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BLPH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.344.72483.93014.3065,371-0.18-4.15%
1 Month4.744.983.93014.4593,040-0.58-12.24%
3 Months4.025.953.795.03191,6180.143.48%
6 Months6.999.1853.795.37131,485-2.83-40.49%
1 Year12.7813.223.796.5396,341-8.62-67.45%
3 Years2.5029.910.274.56349,1181.6666.4%
5 Years1.6029.910.273.11393,7782.56160.0%

Bellerophon Therapeutics Description

Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. The firm develops innovative products combining novel drugs and devices to treat cardiopulmonary diseases. It develops products under its INOpulse platform, which is an extension of the technology that is used in hospitals to deliver continuous-flow inhaled nitric oxide. The company products are aimed at the treatment of different kinds of pulmonary hypertension.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210801 02:20:16